Considering that butyrate can regulate mitochondrial fatty acid β-oxidation through epigenetic mechanisms to prevent HFD-induced insulin insensitivity and improve obesity-related characteristics, the utilization of F prausnitzii or its derivatives may present a promising alternative for the treatment of intestinal diseases associated with obesity and its complications. Here, INS is linked to obesity disorder.